Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Apyx Medical Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of APYX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders54151−2
Shares20.9M945.7K18.2M−1.79M (−9.0%)
Value$94.0M$4.25M$42.6M−$47.1M (−52.6%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Apyx Medical Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to APYX in Q4 2022
InstitutionSharesValue% of portfolio
Barclays PLC842,145$1.97M0.00%
Acadian Asset Management LLC230,374$537.0K0.00%
Gsa Capital Partners LLP91,688$215.0K0.03%
XTX Topco Ltd20,371$47.7K0.01%
ProVise Management Group, LLC13,499$31.6K0.00%
Grey Fox Wealth Advisors, LLC1,993$4.66K0.00%
Colonial Trust Co1,329$3.00K0.00%
Creative Financial Designs Inc1,000$2.34K0.00%
Federated Hermes, Inc.186$4350.00%
GWM Advisors LLC117$00.00%

Sold out (12)

Institutions that held Apyx Medical Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of APYX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Kent Lake Capital LLC1,049,273$4.71M
Next Century Growth Investors LLC341,146$1.53M
Banco Santander, S.A.125,000$561.0K
White Pine Capital LLC99,974$449.0K
Ergoteles LLC41,866$188.0K
Qube Research & Technologies Ltd32,418$146.0K
Cubist Systematic Strategies, LLC12,814$58.0K
Virtu Financial LLC11,536$52.0K
Jump Financial, LLC10,500$47.0K
Tower Research Capital LLC (TRC)7,147$32.0K
MCF Advisors LLC438$2.00K
Bogart Wealth, LLC75$0

Not filed for Q4 2022 yet (1)

Institutions that held Apyx Medical Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APYX in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Invenire Partners, LP945,711$4.25M